• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

AB Blood Group is Associated with Cognitive Impairment

September 26, 2014

tx_news_26_septIn a recent case-controlled study published in Neurology, researchers assessed the relationship between ABO blood group, factor VIII, and the incident cognitive impairment.

Compared to blood group O, blood group AB individuals had an increased risk of cognitive decline after adjusting for age, race, religion, and sex (odds ratio=1.82, 95% CI=1.15-2.90) and had higher factor VIII plasma levels. Factor VIII accounted for less than 20% of the association between AB blood group and cognitive impairment. Further studies are needed to define the relationship and underlying mechanisms between cognitive impairment and blood type.

Reference

1. Alexander KS, Zakai NA, Gillett S, McClure LA, Wadley V, Unverzagt F, Cushman M. ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort. Neurology 2014.

Filed Under

  • News
  • Serology/Genotyping

Recommended

  • AABB Bulletin Highlights Recommendations to Reduce the Risk of Transfusion-Related Acute Lung Injury (TRALI)

  • Recommendations for Patient Blood Management in Adults

  • Whole Blood Transfusions on the Battlefield

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Recombinant ADAMTS13 for Treatment of Congenital Thrombotic Thrombocytopenic Purpura

  • Peripheral Blood Stem Cell Collection Versus Bone Marrow Harvest for Individuals with Sickle Cell Trait

  • Oral Mitapivat to Treat Transfusion-Dependent Thalassemia

  • Increased Mortality in Trauma Patients with Non-identical ABO Transfusions

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley